Identity and Botanical Classification
Nomenclature and Taxonomy
Robinia pseudoacacia L. is a medium-sized hardwood deciduous tree belonging to the tribe Robinieae of the legume family (Fabaceae). Its other common name is "false acacia," a literal translation of the specific epithet (pseudo, Greek for "fake" or "false," and acacia, referring to the superficially similar genus). The species is also widely known as black locust in North American English usage. Within the genus Robinia, the genus commonly known as locust comprises approximately 10 species of trees and shrubs characterized by white or pink flowers with an intensive, distinctive, sweet aroma.
Geographical Origin and Distribution
Although fossilized traces of the genus were found in Europe, the species itself is native to a few small areas of the United States, but has been widely planted and naturalized elsewhere, including temperate North America, Eurasia, and Africa. It is considered an invasive species in some regions. Originally native to the south-eastern USA, it is now widely distributed as both wild and cultivated species growing in temperate regions throughout the world.
Morphology and Parts Used
The flowers are white, borne in pendulous racemes of 10–15 cm in length, and are edible, with high nutrient and functional values. Medicinally and as a dietary ingredient, the most commonly used parts are the flowers, leaves, bark (inner bark), seeds, and heartwood. Except from the inflorescences, all parts of the plant are toxic, especially the bark and seeds.
Common Preparations and Forms
Documented preparations include aqueous infusions (teas) and decoctions of flowers, ethanolic and methanolic extracts of various plant parts, flower concrete and essential oil, syrup and jam made from flowers, standardized flavonoid-enriched extracts used in phytochemical research, and, more recently, flower-derived exosome-like nanoparticles under experimental investigation. The genus Robinia was named after French botanist Jean Robin, who introduced the tree to Europe in the 1600s.
Traditional and Historical Use
Indigenous North American Use
The black locust has a rich history tied to both North American ecology and global horticulture. Native to the eastern U.S., it was used by Indigenous peoples, such as the Cherokee, for tools, bows, and medicinal purposes, leveraging its durable wood and the astringent properties of its bark.
European Herbal Traditions
The flowers, bark, and leaves of R. pseudoacacia have been used in traditional medicine for antitussive, laxative, and cholagogue purposes. In European folk medicine, flower-based preparations were particularly prominent. The flowers of false acacia are used in traditional medicine as diuretic, spasmolytic, sedative, and cholagogic agents, and to relieve inflammation of the kidneys and biliary ducts.
In Eastern European folk practice, the tradition is documented among Ukrainian and Polish communities. In the Polesie region, black locust syrup is used as an antispasmodic, expectorant, diuretic, choleretic, sedative, hemostatic, antipyretic, laxative, hypotensive, anti-inflammatory, and healing agent. Black locust flowers are especially valued as an antipyretic, and also for the prevention of diseases of the lungs and bronchi, as well as an effective antispasmodic for spasms of internal organs or muscles.
In traditional medicine of India, different parts of R. pseudoacacia are used as laxative, antispasmodic, and diuretic. In Liguria, Italy, and Romania, the flowers are sometimes used to produce a sweet and perfumed jam.
Use as Food
Investigation of the chemical composition of R. pseudoacacia showed that the flowers are rich in proteins and microelements, which could be used as additives in foods. The flowers of Robinia pseudoacacia L. are edible and similar in appearance to those of Sophora japonica L. The flowers are consumed fresh, fried in batter, or processed into jams and syrups throughout much of Eastern Europe and China.
Black Locust Honey
Robinia pseudoacacia (black locust) is the main honey-bearing tree that grows spontaneously in Romania, especially in the plains and hills. Robinia pseudoacacia and Helianthus annuus are important sources of nectar for the production of two monofloral honeys with specific characteristics and important biological activity. Acacetin has been proposed as a biochemical marker for Romanian Robinia honey, distinguishing it from sunflower honey.
Key Constituents and Active Compounds
Flavonoids
Flavonoids are the principal and best-characterized class of bioactive compounds in R. pseudoacacia. In the chemical composition of Robinia pseudoacacia L. species, the following flavonoids have been cited in the literature: robinin (kaempferol-3-O-ramnozil-galactozil-7-ramnozid) and acacetin-7-O-rutosid, apigenin, diosmetin, luteolin, as well as secundiflorol, mucronulatol, isomucronulatol, and isovestitol.
The main flavonoids in R. pseudoacacia are quercetin, rutin, kaempferol, robinin, and acacetin, which play vital roles in resistance to environmental stresses.
Flavonoid glycosides are the main constituents found in the flowers. The main aglycon moieties found in Robinia pseudoacacia flowers (RPF) are acacetin and kaempferol. Kaempferol-di(rhamnoside)-hexoside is the most dominant flavonoid in RPF, with a content range of 25.94–30.00 mg/g.
Acacetin
Acacetin's A-ring bears hydroxyl groups at C-5 and C-7, whereas the B-ring carries a methoxy group at C-4′; these features shape its physicochemical behavior and target engagement in biological systems. In nature, acacetin acts as an aglycone and glycoside in multiple edible or medicinal taxa. It has been isolated from black locust (Robinia pseudoacacia), bee propolis, Dracocephalum moldavica, Turnera diffusa, and Betula pendula.
Robinetin
Robinetin is a naturally occurring polyhydroxylated flavonol that has gained attention due to its broad spectrum of biological activities and potential therapeutic applications. A comprehensive 2025 review presents a summary of current knowledge concerning its natural occurrence, extraction, spectroscopic characterization, and pharmacological properties. The mature heartwood of R. pseudoacacia contains two main flavonoid extractives: dihydrorobinetin (the most abundant) and robinetin, which exhibit interesting biological activities.
Phenolic Acids and Other Polyphenols
In total, 64 phenolic compounds have been identified across leaf and flower extracts, of which flavonols (20 compounds) and hydroxycinnamic acid derivatives (15 compounds) were the most represented. Flavanols such as catechin dominated in leaf extracts, followed by flavonols, with kaempferol glucuronyl rhamnosyl hexoside as the main compound. Flower extracts had the highest share of flavones, followed by ellagitannins, with luteolin dirhamnosyl hexosides and vescalagin as predominant compounds.
The flowers of R. pseudoacacia are also a source of luteolin, gallic acid, and caffeic acid, which are known as antioxidant, anti-inflammatory, and antimicrobial agents.
Lectins (Toxalbumins)
The black locust (Robinia pseudoacacia) tree contains toxalbumins, robin and phasin, that exert their toxic effects by inhibition of protein synthesis. Two lectins, RPA 1 and RPA 3, have been purified from Robinia pseudoacacia seeds. These two lectins differ in their physicochemical and biological properties. Both lectins exerted a mitogenic effect on human peripheral-blood lymphocytes. Concentrations between 0.5 and 1 microgram of RPA 3/ml gave optimal proliferative responses.
Alkaloids, Tannins, and Steroids
The bioactive molecules present in R. pseudoacacia include alkaloids, flavonoids, tannins, phenols, and steroids. The toxic compounds in the bark include the glycoside (robitin), the alkaloid (robinin), and the lectins (robin, ricin, and phasin).
Heartwood Extractives
Robinia pseudoacacia L. produces wood with very high natural durability and its mature heartwood contains two main flavonoid extractives, dihydrorobinetin—the most abundant—and robinetin, both of which present interesting biological activities.
Flavonoid Distribution Across Plant Parts
Chromatographic analysis showed a higher concentration of flavonoids in flowers than in leaves. The flowers harvested in the plains have a higher concentration of hyperoside (0.9 mg/mL) compared with the flowers collected from the hills (0.54 mg/mL). The leaves are richer in ruthoside (0.98 mg/mL) compared with the flowers.
Established Mechanisms of Action
Antioxidant Activity
Results of multiple studies show that the flowers are rich in phenolic compounds and have significant antioxidant activity. Total phenolics and flavonoids, as well as antioxidant capacity measured by ABTS (17.49–146.41 mg TE/g DW), DPPH (24.67–118.49 mg TE/g DW), and FRAP (7.38–77.53 mg TE/g DW) assays, were higher in leaf than in flower extracts. Despite limited water solubility, robinetin's redox behavior and metal-chelating capabilities support its antioxidant potential.
Anti-inflammatory and Anti-angiogenic Mechanisms
In experimental systems, R. pseudoacacia leaf extract (RP) inhibited secretion of SEAP, blocked IL-1β signaling, and inhibited IL-1β–mediated angiogenesis. RP inhibited nuclear translocation of NF-κB by suppressing phosphorylation of IL-1β signaling protein kinases and inhibited mRNA expression of IL-1β–induced pro-angiogenic factors including VEGFA, FGF2, ICAM1, CXCL8, and IL-6.
Antimicrobial Mechanisms
R. pseudoacacia contains flavonoids including robinin, acacetin-7-O-rutoside, apigenin, diosmetin, luteolin, secundiflorol, mucronulatol, isomucronulatol, and isovestitol, which are of pharmaceutical importance. These plant compounds have a number of documented medicinal uses including antacid, antibacterial, antifungal, purgative, and emmenagogic effects.
Enzyme Inhibition
Robinetin exhibits diverse bioactivities, including antiviral, antibacterial, antiparasitic, antioxidant, anti-mutagenic, and enzyme-inhibitory effects. Notably, it inhibits HIV-1 integrase and acetylcholinesterase, and demonstrates moderate antiproliferative activity in cancer cell lines.
Acacetin: Multi-target Oncological Mechanisms
Acacetin demonstrates distinctive advantages by directly targeting EGFR, STAT3, and AKT, and by uniquely influencing necroptosis, PD-L1 expression, and angiogenesis. Acacetin inhibits the activities and functions of both ABCB1 and ABCG2. By downregulating ABCB1 in non-small cell lung cancer (NSCLC) cells, acacetin decreases efflux of doxorubicin by 59% and further increases accumulation of doxorubicin inside cells by up to 55%, leading to synergistic cytotoxic effects.
Gastrointestinal Mucosal Protection
Oral administration of R. pseudoacacia L. flower exosome-like nanoparticles (RFELNs) significantly ameliorated hypoxia-induced gastric and small intestinal mucosal injury in mice by downregulating hypoxia-inducible factor-1α (HIF-1α) and HIF-2α expression and inhibiting hypoxia-mediated ferroptosis. In vitro experiments showed that cell death under 1% O₂ mainly occurred via ferroptosis. RFELNs inhibited HIF-1α and HIF-2α expression and downregulated NOX4 and ALOX5, which drive reactive oxygen species production and lipid peroxidation, respectively, suppressing ferroptosis under hypoxia.
Scientific Evidence by Area of Use
Antioxidant Activity
Evidence type: In vitro / analytical chemistry. Strength: Consistent but limited to laboratory models.
Research has specifically examined the correlation between Robinia pseudoacacia flowers' polyphenolic compounds and their chemical and biological effects. Multiple independent analytical studies have quantified antioxidant capacity across plant parts and preparations using ABTS, DPPH, and FRAP assays. Compounds were extracted from leaves and flowers with 70% ethanol and 80% methanol; total phenolics, flavonoids, and antioxidant capacity as measured by ABTS (17.49–146.41 mg TE/g DW), DPPH (24.67–118.49 mg TE/g DW), and FRAP (7.38–77.53 mg TE/g DW) assays, were higher in leaf than in flower extracts. No controlled human clinical trials have evaluated the antioxidant effects of R. pseudoacacia preparations in vivo. Evidence remains at the in vitro stage.
Antimicrobial Activity
Evidence type: In vitro microbiological assays. Strength: Preliminary; no human clinical trials.
A microbiological study evaluated the antibacterial potential of extracts of Robinia pseudoacacia and its different fractions, as well as some of its natural compounds, against oral pathogens and a nonpathogenic reference bacterium, Escherichia coli. The chloroform and hexane fractions were active against P. gingivalis, with 91% and 97% growth inhibition, respectively, at 0.2 mg/mL. None of seven natural compounds found in R. pseudoacacia exerted an antibacterial effect on P. gingivalis; however, fisetin and myricetin at 8 µg/mL inhibited the growth of S. mutans by 81% and 86%, respectively.
Antibacterial and antifungal effects were evaluated by the Kirby-Bauer disc diffusion method against multiple infectious agents. Extracts from various parts of the plant showed different antibacterial activities. Extracts of flowers and seeds were efficient antibacterials for Gram-positive cocci. Bark and leaf extracts were active against Escherichia coli, Pseudomonas, Proteus, Salmonella choleraesuis, and Candida albicans.
R. pseudoacacia flowers were found to have high levels of phenolic compounds and minerals with pronounced antioxidant properties. The aromatic substances and phenolic compounds in the extracts exhibit antimicrobial properties against foodborne pathogenic bacteria including Salmonella, Escherichia coli, and Listeria monocytogenes. All antimicrobial evidence is limited to in vitro laboratory models. No clinical or human intervention trials have been conducted.
Anti-inflammatory and Anti-cancer Activity
Evidence type: In vitro cell-based assays and ex vivo models. Strength: Preliminary; no clinical human data.
A study aimed to demonstrate the inhibitory effects of Robinia pseudoacacia leaf extract (RP) on IL-1β–mediated tumor angiogenesis using SEAP reporter gene assay, ex vivo and in vitro tube formation assay, western blot, and quantitative PCR. Results showed RP inhibited secretion of SEAP, blocked IL-1β signaling, and inhibited IL-1β–mediated angiogenesis in ex vivo and in vitro assays. RP inhibited nuclear translocation of NF-κB by suppressing phosphorylation of IL-1β signaling protein kinases and inhibited mRNA expression of IL-1β–induced pro-angiogenic factors including VEGFA, FGF2, ICAM1, CXCL8, and IL-6.
In a bioactivity-guided fractionation study, five isolated flavonoids were tested for cytotoxicities against a panel of six solid human tumor cell lines; acacetin (compound 1) was significantly cytotoxic in the prostate cell line (PC-3). Studies have reported that R. pseudoacacia leaf extract has been found to inhibit cancer cell proliferation and migration. All cancer-related evidence is from in vitro and ex vivo experiments; no human clinical oncology trials have been published.
Gastrointestinal and Gut Microbiota Effects
Evidence type: Animal (mouse) models and in vitro cell lines. Strength: Emerging; no human trials.
An increasing number of studies have revealed that plant exosome-like nanoparticles (PELNs) can improve the intestinal microbiota and exert antioxidant effects. Oral administration of Robinia pseudoacacia L. flower exosome-like nanoparticles (RFELNs) significantly ameliorated hypoxia-induced gastric and small intestinal mucosal injury in mice by downregulating HIF-1α and HIF-2α expression and inhibiting hypoxia-mediated ferroptosis.
In an experimental ulcerative colitis mouse model, RFELNs restored intestinal barrier function in UC mice by activating AhR/IL-22 signaling through regulation of gut microbiota-dependent tryptophan metabolism. These are preclinical animal and cell-line studies. Translation to human gastrointestinal disease has not been established.
Cytotoxicity and Bioactivity Against Cancer Cell Lines
Evidence type: In vitro cell assays and in silico (computational) models. Strength: Preliminary.
A bioactivity-directed study was conducted to identify novel bioactive organic chemical constituents from ethanolic extracts of the black locust tree (Robinia pseudoacacia L., Fabaceae). Screening assays demonstrated that these extracts had significant activity in the brine shrimp lethality test (BST) and human tumor cytotoxicity assays (MTIF assays); in addition, the species has had many interesting folkloric medicinal uses. However, the bioactive principles of the plant had not previously been identified.
Recent in vivo studies indicate robinetin's hepatoprotective and metabolic regulatory effects. Additionally, computational models reveal promising interactions with molecular targets such as CDK1.
Dental and Oral Health
Evidence type: In vitro laboratory assays. Strength: Preliminary.
Extracts of R. pseudoacacia had good quorum sensing, biofilm formation prevention, and eradicating capacity. The results provided new insights into the phytochemical properties of R. pseudoacacia as the first step toward its potential pharmaceutical use. These results indicate the effectiveness of the plant in potential clinical applications for the treatment of dental plaque and periodontal inflammatory diseases and its potential use as a disinfectant for various surgical and orthodontic appliances. These conclusions are based on in vitro assays only.
Body Systems and Health Areas Associated with Robinia pseudoacacia
- Gastrointestinal system: Historically used as a spasmolytic and cholagogic agent to relieve inflammation of the kidneys and biliary ducts. Flowers consumed in teas for digestive discomfort, heartburn, and mild gastritis.
- Respiratory system: Used in traditional medicine for antitussive purposes. Flowers valued for the prevention of diseases of the lungs and bronchi.
- Urinary system: Used in traditional medicine as a diuretic agent.
- Immune and inflammatory pathways: Leaf extract shown in laboratory models to block IL-1β signaling and inhibit NF-κB nuclear translocation.
- Oncology (experimental): Research has found R. pseudoacacia extract to inhibit cancer cell proliferation and migration.
- Oral and dental health: The crude extract of R. pseudoacacia possesses bioactive compounds that could completely control the growth of P. gingivalis in vitro.
- Cardiovascular system (indirect/traditional): Used traditionally as a hypotensive agent.
- Nervous system (traditional): Used as a sedative agent in traditional medicine.
- Gut microbiota and mucosal barrier: Flower-derived nanoparticles shown in mouse models to restore intestinal barrier function via AhR/IL-22 signaling.
Dosage Forms and Doses Reported in Studies
No human clinical trials establishing therapeutic dosages have been published. Dosages reported are derived from in vitro and animal experimental studies only.
- In vitro antimicrobial assays (crude extract and fractions): The chloroform and hexane fractions of R. pseudoacacia were tested at a concentration of 0.2 mg/mL against P. gingivalis, achieving 91% and 97% growth inhibition, respectively.
- In vitro antimicrobial assays (isolated compounds): Fisetin and myricetin, isolated from R. pseudoacacia, inhibited the growth of S. mutans by 81% and 86%, respectively, at 8 µg/mL.
- In vitro cytotoxicity (cancer cell lines): A wound-healing (scratch) assay was conducted using C6 cell line in the presence of a methanolic extract of R. pseudoacacia at 50 µg/mL.
- Lectin mitogenesis (isolated lectins, ex vivo): For lectin RPA 3 purified from seeds, concentrations between 0.5 and 1 microgram/mL gave optimal mitogenic (proliferative) responses in human peripheral-blood lymphocytes.
- Traditional preparations (ethnographic record): Flower teas, decoctions, and syrups are documented in folk practice, but standardized amounts are not specified in the peer-reviewed sources reviewed.
Safety Considerations
Organ-Specific Toxicity: Bark, Seeds, and Leaves
The bark, leaves, and wood are toxic to both humans and livestock. Important constituents of the plant are the toxalbumin robin, which loses its toxicity when heated, and robinin, a nontoxic glucoside. The black locust tree contains toxalbumins, robin and phasin, that exert their toxic effects by inhibition of protein synthesis.
Differential Toxicity by Plant Part
Except from the inflorescences, all parts of the plant are toxic, especially the bark and seeds. The toxic compounds include the glycoside (robitin), the alkaloid (robinin), and the lectins (robin, ricin, and phasin). Robin is one of the main toxins of this tree, and its concentration is highest in the bark.
Documented Human Poisoning Cases
Despite the potential dangers of black locust intoxication, reports of human toxicity after ingestion are rare. A case report documented the first human intoxication of black locust bark in North America in over one hundred years. A clinical-epidemiological study of an accidental poisoning by Robinia pseudoacacia L. in six school children was conducted; the children had sucked and/or chewed the bark of this plant. The clinical symptoms were abdominal pain, thirst, nausea, vomiting, dry throat, muscle weakness, mydriasis, headache, dizziness, and diarrhea. Treatment included activated charcoal in 5 cases and subsequent gastric lavage in 3 cases.
Veterinary Toxicity
Horses that consume the plant show signs of anorexia, depression, incontinence, colic, weakness, and cardiac arrhythmia. Symptoms usually occur about 1 hour following consumption, and immediate veterinary attention is required. A case report described the poisoning of two mares from the same paddock with Robinia pseudoacacia bark. The poisoning manifested as a sudden onset of weakness and fever with transient improvement after the administration of non-steroidal anti-inflammatory drugs and fluids. After the initial stabilization, the mares were left unattended overnight; one of them was found dead in the morning.
Flowers Considered Separately Safe for Edible Use
Except from the inflorescences, all parts of the plant are toxic. The edible status of the fresh flowers is consistent across botanical literature, but the bark and seeds should be used more cautiously due to their known toxicity in large quantities.
Absence of Human Clinical Safety Data
Despite promising findings from in vitro and animal research, robust human clinical trials investigating the nutritional or therapeutic effects of Robinia pseudoacacia remain lacking. No formal toxicological studies in humans, no established tolerable upper intake levels, and no official monograph from regulatory bodies such as the German Commission E, ESCOP, or EMA have been published specifically for R. pseudoacacia flower or bark preparations as a dietary supplement.
Invasive Species Regulatory Status
In 2014, a political conflict arose when the European Union considered classifying Robinia pseudoacacia as an invasive species. The Hungarian government opposed this classification, declaring the tree a "Hungaricum"—a protected element of national cultural heritage—effectively politicizing the species' biological status.
Summary of Evidence Strength
The available evidence for Robinia pseudoacacia as a medicinal or dietary supplement ingredient can be characterized as follows:
- Phytochemical characterization: Well-established. Multiple peer-reviewed studies have comprehensively mapped flavonoid, phenolic acid, lectin, and alkaloid profiles across different plant parts and geographic sources.
- Antioxidant activity: Consistently demonstrated in in vitro assays; no human data available.
- Antimicrobial activity: Demonstrated in vitro against oral pathogens and foodborne bacteria; clinical relevance unconfirmed.
- Anti-inflammatory/anti-cancer properties: Mechanistic evidence from cell-based and ex vivo models is promising, particularly for NF-κB inhibition and anti-angiogenic effects; no human or clinical trial data exist.
- Gastrointestinal mucosal protection: Emerging evidence from mouse models using novel nanoparticle preparations; not validated in humans.
- Traditional use evidence: Broad and geographically diverse, but ethnographic in nature and not corroborated by controlled human clinical studies.
- Safety: Flowers are widely consumed as food without documented adverse effects at normal food intakes; non-floral plant parts (bark, seeds, leaves, wood) contain protein-synthesis-inhibiting toxalbumins and should not be used without proper processing and expert guidance.
References
Go back